Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$48K Buy
700
+500
+250% +$39.1K ﹤0.01% 6882
2014
Q2
$16K Sell
200
-400
-67% -$27.1K ﹤0.01% 8357
2014
Q1
$41K Sell
600
-2,600
-81% -$193K ﹤0.01% 7115
2013
Q4
$228K Buy
3,200
+1,800
+129% +$140K ﹤0.01% 5157
2013
Q3
$107K Sell
1,400
-3,300
-70% -$228K ﹤0.01% 5938
2013
Q2
$305K Buy
+4,700
New +$252K ﹤0.01% 4622

Other funds holding PRLB

UBS's PRLB Position: Q3 2014 in Review

UBS reduced its Protolabs (PRLB) stake by 39% in Q3 2014, selling an estimated $2M and leaving 40,167 shares worth $2.77M. The position accounts for ﹤0.01% of the portfolio, ranked #2600.

UBS first reported a position in PRLB in Q2 2013 and has held it in 6 quarters since. The position peaked at $9.2M in Q4 2013. 186 funds tracked by Wall St. Rank hold PRLB as of Q3 2014.

  • UBS held 40,167 shares of Protolabs worth $2.77M as of Q3 2014.
  • UBS sold 25,514 Protolabs shares in Q3 2014, an estimated $2M.
  • Protolabs made up ﹤0.01% of UBS's portfolio in Q3 2014, its #2600 holding.
  • UBS first reported a position in Protolabs in Q2 2013 and has held it in 6 quarters since.
  • UBS's Protolabs position peaked at $9.2M in Q4 2013.
  • 186 funds tracked by Wall St. Rank held Protolabs as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.